Core Insights - Elbit Systems reported strong financial results for the fourth quarter and full year of 2025, with revenues increasing by 16% year-over-year to $7.9 billion and a GAAP net income of $534 million, reflecting a 66% increase from the previous year [1][27][28] Financial Performance - Revenues for the fourth quarter of 2025 rose by 11.3% to $2.15 billion compared to $1.93 billion in the fourth quarter of 2024 [5] - For the full year 2025, revenues increased by 16.3% to $7.94 billion from $6.83 billion in 2024 [14][15] - GAAP net income for the fourth quarter was $168.2 million (7.8% of revenues), up from $90 million (4.7% of revenues) in the same quarter of 2024 [13] - Non-GAAP net income for the fourth quarter was $169.9 million (7.9% of revenues), compared to $119.3 million (6.2% of revenues) in the fourth quarter of 2024 [13] - The company achieved a GAAP net EPS of $11.39 for the full year, a 59% increase from $7.18 in 2024 [28] Order Backlog and Cash Flow - The order backlog reached $28.1 billion, an increase of $5.5 billion from the previous year [29] - Free cash flow for 2025 was over $550 million, indicating a 100% cash conversion rate [2] Segment Performance - C4I and Cyber revenues increased by 19% due to sales of radio and command systems [6] - ISTAR and EW revenues grew by 39%, driven by sales of maritime and electro-optic systems [6] - Land revenues rose by 22%, primarily from ammunition sales in Israel and Europe [6] - Aerospace revenues decreased by 14% due to lower training and simulation sales [6] Research and Development - The company invested over $500 million in R&D, focusing on AI enhancements across multiple platforms [4] - Research and development expenses for 2025 were $517.1 million, representing 6.5% of revenues, up from $466.4 million (6.8% of revenues) in 2024 [17] Recent Contracts and Strategic Developments - Significant contracts were secured, including a $210 million contract for upgrading Merkava Main Battle Tanks and a $275 million contract for airborne self-protection systems [35][37] - The company continues to strengthen its presence in global markets, particularly in Europe, the U.S., and Asia [3] Operational Challenges - The ongoing conflicts in the Middle East have led to increased demand for Elbit Systems' products from the Israel Ministry of Defense [32] - Some operations faced disruptions due to supply chain constraints and increased transportation costs [33]

Core Insights - Elbit Systems reported strong financial results for the fourth quarter and full year of 2024, with a backlog of orders totaling $22.6 billion and revenues of $6.8 billion, reflecting a 14% increase from 2023 [1][15][31]. Financial Performance - Fourth quarter revenues reached $1,930.2 million, up from $1,625.8 million in the same quarter of 2023, marking a significant year-over-year growth [4][15]. - Non-GAAP net income for the fourth quarter was $119.3 million (6.2% of revenues), compared to $69.7 million (4.3% of revenues) in the fourth quarter of 2023 [13][31]. - GAAP net income for the fourth quarter was $90.0 million (4.7% of revenues), up from $30.0 million (1.8% of revenues) in the fourth quarter of 2023 [13][31]. - For the full year 2024, non-GAAP net income attributable to shareholders was $391.5 million (5.7% of revenues), compared to $298.8 million (5.0% of revenues) in 2023 [31]. - GAAP net income for the full year was $321.1 million (4.7% of revenues), an increase from $215.1 million (3.6% of revenues) in 2023 [31]. Revenue Segmentation - Aerospace revenues increased by 27% in Q4 2024, driven by higher UAS revenues in Israel and Europe, and increased Precision Guided Munition (PGM) revenues [5]. - C4I and Cyber revenues rose by 7%, primarily due to sales of radio systems and command and control systems [5]. - Land revenues surged by 29%, mainly due to increased sales of ammunition and munitions in Israel [5][16]. - Elbit Systems of America revenues increased by 6%, attributed to higher sales of night-vision systems and medical instrumentation [5]. Operational Highlights - The company generated $320 million in free cash flow during the fourth quarter [3]. - Research and development expenses for Q4 2024 were $131.2 million (6.8% of revenues), compared to $117.4 million (7.2% of revenues) in Q4 2023 [7][19]. - Marketing and selling expenses for Q4 2024 were $107.2 million (5.6% of revenues), up from $91.3 million (5.6% of revenues) in Q4 2023 [7][20]. - General and administrative expenses decreased to $85.4 million (4.4% of revenues) in Q4 2024, down from $105.9 million (6.5% of revenues) in Q4 2023 [8][20]. Backlog and Future Outlook - The order backlog as of December 31, 2024, was $22.6 billion, an increase from $17.8 billion at the end of 2023, with approximately 65% of the backlog from international orders [33]. - About 57% of the current backlog is scheduled for execution in 2025 and 2026 [33]. - The company has experienced increased demand for its products from the Israel Ministry of Defense due to the ongoing conflict, with contracts awarded totaling over $5 billion during 2024 [34][35].